Filing Details
- Accession Number:
- 0001127602-16-066219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-07 13:05:49
- Reporting Period:
- 2016-11-03
- Filing Date:
- 2016-11-07
- Accepted Time:
- 2016-11-07 13:05:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238334 | Daniel Jonas | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Evp Legal Affairs,Gen. Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-03 | 2,000 | $19.26 | 20,120 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-03 | 1,360 | $39.18 | 18,760 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2016-11-03 | 4,000 | $27.63 | 22,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-03 | 3,257 | $39.18 | 19,503 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2016-11-03 | 4,000 | $26.09 | 23,503 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-03 | 3,158 | $39.18 | 20,345 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-11-07 | 2,555 | $40.40 | 17,790 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2016-11-03 | 2,000 | $0.00 | 2,000 | $19.26 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2016-11-03 | 4,000 | $0.00 | 4,000 | $27.63 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2016-11-03 | 4,000 | $0.00 | 4,000 | $26.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-06-01 | No | 4 | M | Direct | |
| 0 | 2021-06-01 | No | 4 | M | Direct | |
| 2,000 | 2022-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $40.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Billionaire Hedge Funds
